Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 16849761

Phase II study of pemetrexed for second-line treatment of transitional cell cancer of the urothelium.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2006 Jul 20
First author
Sweeney CJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Sweeney CJ
      type
      Author
    2. name
      Roth BJ
      type
      Author
    3. name
      Kabbinavar FF
      type
      Author
    4. name
      Vaughn DJ
      type
      Author
    5. name
      Arning M
      type
      Author
    6. name
      Curiel RE
      type
      Author
    7. name
      Obasaju CK
      type
      Author
    8. name
      Wang Y
      type
      Author
    9. name
      Nicol SJ
      type
      Author
    10. name
      Kaufman DS
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Sweeney CJ
      type
      Author
    2. name
      Roth BJ
      type
      Author
    3. name
      Kabbinavar FF
      type
      Author
    4. name
      Vaughn DJ
      type
      Author
    5. name
      Arning M
      type
      Author
    6. name
      Curiel RE
      type
      Author
    7. name
      Obasaju CK
      type
      Author
    8. name
      Wang Y
      type
      Author
    9. name
      Nicol SJ
      type
      Author
    10. name
      Kaufman DS
      type
      Author
    bibliography ids
    1. nci-bib-49ed48dd1479a8fb9f309826
    book metadata
    content sha256
    eeafd011171d8567c91bfd1ef7b32e0a98c27fe62c6b05c2d98cbdc0f509758f
    document type
    citation
    dois
    1. 10.1200/JCO.2005.03.6699
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:16849761
    immutable id
    pubmed:16849761@eeafd011171d8567c91bfd1ef7b32e0a98c27fe62c6b05c2d98cbdc0f509758f
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    21
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    3451-7
    volume
    24
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      16849761
      provenance
      batch id
      19fb2de9a00882c94e86
      provider
      NCBI PubMed ESummary
      record sha256
      27d8917335f10c578e9bf74c2a8b545a5e82950d3b89b4916462302e55299c3e
      response sha256
      4c446464d8fd06bff771a2bb5f3529ef4abe372e3c19f6fb7223068d839a263d
      retrieved at
      2026-09-09T23:46:06.810486+00:00
      publication date
      display
      2006 Jul 20
      precision
      day
      year
      2006
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/16849761/
      title
      Phase II study of pemetrexed for second-line treatment of transitional cell cancer of the urothelium.

      Preserved source evidence · Not medical advice